Northwire Canada EditionTuesday, August 25, 2026
Northwire
GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0% GOLD 4697.80 +0.4% SILVER 68.59 −1.4% COPPER 6.61 +0.3% OIL 85.01 −2.4% PALLADIUM 1359.75 +0.7% NVO 0.070 +0.0% SRA 0.780 +0.0% TUK 0.020 −20.0% GWM 0.610 −4.7% MINE 0.110 +0.0% EGM 0.100 +0.0% IRO 1.11 +2.8% CBR 1.41 +2.5% CTN 0.045 +0.0% GMX 2.06 +2.0% NPR 0.700 −2.8% CGD 1.28 +8.5% CRE 0.390 +13.0% PE 0.250 +0.0% PER 0.150 +7.1% SVRS 0.540 +8.0%
Financings Routine +

Cheelcare Announces Upsizing of Non-Brokered Private Placement to $3.0 Million

CHER · Price

Executive Summary

  • Cheelcare Inc. has increased the size of its previously announced non-brokered private placement financing due to strong investor demand.
  • The offering will issue up to 2,000,000 units at $1.50 per unit, raising up to $3,000,000 in aggregate gross proceeds.
  • Proceeds will be directed toward general working capital, product development, and commercialization, with expected participation from company insiders.

Key Details

  • Financing Structure: Non-brokered private placement offering.
  • Units & Price: Up to 2,000,000 units at $1.50 per unit.
  • Gross Proceeds: Up to $3,000,000.
  • Warrant Terms: Each unit consists of one common share and one-half of one common share purchase warrant. Each whole warrant entitles the holder to purchase one additional share at $2.25 per share for a period of two years from the date of closing.
  • Warrant Acceleration Clause: If the TSXV closing price equals or exceeds $3.00 for 10 consecutive trading days, the Company may accelerate the warrant expiry to 30 days after providing notice or issuing a press release. Any unexercised warrants will automatically expire without compensation.
  • Use of Proceeds: General working capital and corporate purposes, including continued product development and commercialization activities.
  • Related Party Transaction: Expected participation from directors, officers, and insiders. The Company will rely on MI 61-101 exemptions (Sections 5.5(a) and 5.7(1)(a)) as the fair market value of securities issued to insiders is not expected to exceed 25% of the Company's market capitalization.
  • Closing Conditions: Subject to acceptance by the TSX Venture Exchange and other customary closing conditions.
  • Hold Period: Units and all underlying securities will be subject to a statutory hold period of four months and one day from their date of issue.
  • Finder's Fees: The Company may pay finder's fees in connection with certain subscriptions, in accordance with TSX Venture Exchange policies.
Read the original news release →

More from Cheelcare Inc.